Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
NCT07615881 Ipilimumab Melanoma, Cutaneous Malignant Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07615881 clinical trial report covering Ipilimumab, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600125907 Umbilical Cord Mesenchymal Stem Cell Exosomes(Sixth Affiliated Hospital, Sun Yat Anemia, Aplastic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
ChiCTR2600125907 clinical trial report covering Umbilical Cord Mesenchymal Stem Cell Exosomes(Sixth Affiliated Hospital, Sun Yat, Phase 1/2, endpoints, spo
Read →
Latest Hotspot
8 min read
NCT07617805 Fludarabine Phosphate Squamous cell carcinoma of head and neck metastatic Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07617805 clinical trial report covering Fludarabine Phosphate, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07618195 EPI-001(Epi Biotech) Androgenetic Alopecia Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07618195 clinical trial report covering EPI-001(Epi Biotech), Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
ChiCTR2600125808 Toripalimab Small Cell Lung Cancer Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
ChiCTR2600125808 clinical trial report covering Toripalimab, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07617493 ICP-B208 Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07617493 clinical trial report covering ICP-B208, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07619482 EYED-002 Glaucoma, Open-Angle Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07619482 clinical trial report covering EYED-002, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07619521 Selumetinib Hydrogen Sulfate Advanced Pancreatic Ductal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07619521 clinical trial report covering Selumetinib Hydrogen Sulfate, Phase 1/2, endpoints, sponsor, geography, readout timing and development white spa
Read →
Latest Hotspot
8 min read
NCT07621159 HDM-2017 Advanced Colorectal Adenocarcinoma Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07621159 clinical trial report covering HDM-2017, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07622940 Fludarabine Phosphate Adenocarcinoma of Esophagus Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07622940 clinical trial report covering Fludarabine Phosphate, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07623486 HSK-44459 Plaque psoriasis Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07623486 clinical trial report covering HSK-44459, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
Latest Hotspot
8 min read
NCT07622225 Enlonstobart Advanced Malignant Solid Neoplasm Clinical Landscape Report 2026: Design, Endpoints, Sponsor and Readout Outlook
7 August 2026
NCT07622225 clinical trial report covering Enlonstobart, Phase 1/2, endpoints, sponsor, geography, readout timing and development white space.
Read →
<
1
<<
233
234
235
236
237
>>
1670
>